Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XH1P
|
|||
| Former ID |
DND000103
|
|||
| Drug Name |
CRx-102
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Discontinued in Phase 2 | [1] | |
| Company |
Zalicus
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00521989) CRx-102 Osteoarthritis Multicenter Evaluation Trial. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.